Home - Products - Others - Other Targets - Ornipressin Acetate(3397-23-7,free)

Ornipressin Acetate(3397-23-7,free)

CAS No. 914453-98-8

Ornipressin Acetate(3397-23-7,free)( Orpressin | POR-8 )

Catalog No. M24956 CAS No. 914453-98-8

Ornipressin Acetate is a potent vasoconstrictor, hemostatic and renal agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 61 In Stock
25MG 117 In Stock
50MG 165 In Stock
100MG 246 In Stock
200MG 365 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ornipressin Acetate(3397-23-7,free)
  • Note
    Research use only, not for human use.
  • Brief Description
    Ornipressin Acetate is a potent vasoconstrictor, hemostatic and renal agent.
  • Description
    Ornipressin Acetate is a potent vasoconstrictor, hemostatic and renal agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Orpressin | POR-8
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    914453-98-8
  • Formula Weight
    1042.2
  • Molecular Formula
    C45H63N13O12S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    NCCC[C@@H](C(NCC(N)=O)=O)NC([C@@H]1CCCN1C([C@@H]2CSSC[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N2)=O)CC(N)=O)=O)CCC(N)=O)=O)Cc3ccccc3)=O)Cc4ccc(O)cc4)=O)N)=O)=O.CC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fruhstorfer H, Heisler M. Dose-response relation of ornipressin with regard to vasoconstriction in human skin. Br J Anaesth. 1994;73(2):220-224. doi:10.1093/bja/73.2.220
molnova catalog
related products
  • resorufin galactopyr...

    resorufin galactopyranoside is a chemical compound.

  • Lufotrelvir

    Lufotrelvir (PF-07304814) is a small molecule inhibitor of the SARS CoV-2 3CL protease for the treatment of COVID-19 with broad-spectrum anti-SARS activity for the study of novel coronavirus infections.

  • CRANAD-28

    CRANAD-28 can mark plaques and cerebral amyloid angiopathy.